Table 2. Bone mineral density and T-scores of the Parkinson’s disease patients and controls.
| Subjects | Males | Females | ||
|---|---|---|---|---|
| PD (n=47) | Controls (n=47) | PD (n=68) | Controls (n=70) | |
| Lumbar spine | ||||
| BMD (g/cm2) | 0.986 ± 0.194* | 1.098 ± 0.170 | 0.804 ± 0.132** | 1.004 ± 0.201 |
| T-score | −0.91 ± 1.75 | −0.59 ± 1.37 | −2.24 ± 1.17** | −1.16 ± 1.65 |
| Femoral neck | ||||
| BMD (g/cm2) | 0.741 ± 0.128** | 0.871 ± 0.148 | 0.650 ± 0.123** | 0.810 ± 0.108 |
| T-score | −2.07 ± 1.18* | −1.43 ± 1.23 | −2.34 ± 1.12** | −1.36 ± 0.87 |
| Total femur | ||||
| BMD (g/cm2) | 0.901 ± 0.148* | 0.995 ± 0.157 | 0.771 ± 0.137** | 0.929 ± 0.129 |
| T-score | −1.27 ± 1.13* | −0.54 ± 1.34 | −1.69 ± 1.06** | −0.56 ± 1.09 |
| Vitamin D (ng/dL) | 12.6 ± 7.6** | 20.6 ± 11.2 | 11.7 ± 6.8** | 18.6 ± 11.4 |
PD: Parkinson’s disease; BMD: bone mineral density. *p<0.05; **p<0.001